Release date: 11/15/24
Expiration date: 1/14/2026
Estimated Time of Completion: 30 minutes
Description
Case Closed: Exploring New Data in Immunoglobulin A Nephropathy is an on-demand, accredited webcast that provides education on the burden of IgAN, the clinical significance of proteinuria in pathophysiology and management, and new and emerging data on novel therapies that can potentially improve patient outcomes.
Learning Objectives
Upon completion of this activity, the participant will be able to:
- Assess burden of IgAN and clinical significance of proteinuria.
- Evaluate emerging data on novel therapies to reduce proteinuria in IgAN.
- Apply the latest data to personalize treatment selection for patients with IgAN.
Target Audience
This educational activity is directed to nephrologists, primary care physicians (PCPs), physician assistants, nurse practitioners, and nurses involved in the care of patients with IgAN.
Accreditation
In support of improving patient care, this activity has been planned and implemented by Cleveland Clinic Center for Continuing Education and Aplastic Anemia & MDS International Foundation. Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 0.50 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Directors
Ali Mehdi, MD, MEd
Department of Kidney Medicine
Glickman Urologic & Kidney Institute
Cleveland Clinic
Cleveland, OH
Faculty
Georges Nakhoul, MD, MEd
Department of Kidney Medicine
Glickman Urologic & Kidney Institute
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in the CME activity are those of the authors/faculty. They do not represent an
endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Ali Mehdi, MD, MEd |
|
| Astra Zeneca, GlaxoSmithKline |
Teaching and Speaking |
| Calliditas Therapeutics, Fresenius, Novartis |
Advisor or review panel participant |
| Georges Nakhoul, MD, MEd |
|
| Amgen, Boehringer Ingelheim, GSK, Otsuka pharmaceuticals |
Consulting |
| Chemocentryx |
Consulting
Teaching and Speaking |
Cleveland Clinic Center for Continuing Education staff members, CME Spark staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Otsuka America Pharmaceutical, Inc.
Travere Therapeutics, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, CME Spark, and Cleveland Clinic’s Department of Kidney Medicine.
Pre Test
Please take before viewing this webcast.
